REG - Induction Healthcare - Directorate Change

Induction HealthcareAnnouncement

04/05/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220504:nRSD1967Ka&default-theme=true

RNS Number : 1967K  Induction Healthcare Group PLC   04 May 2022

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Directorate Change

 

Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that Dr Hugo
Stephenson, who is based in Australia, will stand down from his position as
Group Executive Director, after seeing priority ambitions for the Group
realised during the period of pandemic restrictions, and return to the
Non-executive Director role he originally held on admission to AIM in May
2019.

 

The Board change is a natural evolution of the leadership structure in
response to the strong trading position of the Group at close of FY22, and the
opportunities for face-to-face interaction which are now possible for the UK
based Executive and Senior Management Team as borders re-open. It follows the
completion of the integration of the Attend Anywhere acquisition - where most
of the team was based in Australia - and the most recently announced
successful renewals of Induction Attend Anywhere across NHS England. Both of
these played a part in the positive post-period end trading update of 21 April
2022
(https://www.londonstockexchange.com/news-article/INHC/post-period-end-trading-update/15418598)
.

 

The Company has a dynamic UK based Executive Team in James Balmain (CEO) and
Guy Mitchell (CFO), who was appointed in November 2021
(https://www.londonstockexchange.com/news-article/INHC/directorate-change/15211409)
. James and Guy are supported by a strong Senior Management Team,  including
Dave Williams, who joined as Chief Technology Officer in September 2021
(https://www.londonstockexchange.com/news-article/INHC/directorate-changes/15125043)
.

 

Hugo Stephenson commented: "James and his team have delivered a really strong
end to FY22, providing an exemplary outcome for Attend Anywhere contract
renewals, generating substantial demand for Zesty as the NHS emerges from
pandemic pressures, and establishing a coordinated, global product and
technology organisation that is already demonstrating increased delivery
capability and cross-product efficiency under Dave Williams' leadership.

 

From the outset I have imagined Induction Healthcare as an enabler for
flexible care around the world allowing healthcare systems to offer patients
and providers a range of digital and in-person care options beyond the
resource constrained 'bricks and mortar' models historically available through
hospitals. I stepped into an executive role at the beginning of the pandemic -
from a locked-down basement in Australia - to provide Induction with stability
at a time of great global uncertainty and then a physical link with the Attend
Anywhere team post acquisition. My heart remains in inspiring Induction to
scale worldwide following the impact we are already making in the UK. I am
looking forward to focussing on this mission which I can now do much more
efficiently and effectively from a non-executive position on our Board."

 

Induction CEO, James Balmain, said: "We are indebted to Hugo for his immense
contribution to the business since the commencement of the pandemic during a
period of uncertainty, changing rules, opportunities and challenges. As we
evolve and expand internationally, I'm delighted that Induction will continue
to benefit from his experience and expertise. We all are incredibly excited
about the future prospects for the business."

 

-ENDS-

 

ENQUIRIES

 

 Induction                                                 Via Walbrook PR Ltd: induction@walbrookpr.com

                                                         (mailto:induction@walbrookpr.com)
 James Balmain, Chief Executive Officer
 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)     +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd              +44 (0)20 7933 8780 or induction@walbrookpr.com
                              (mailto:induction@walbrookpr.com)
 Paul McManus / Alice Woodings                             Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

About Induction -  www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUPUUGAUPPPUW